البحث عن طبيب

R. Scott Wright, M.D.

  1. Cardiologist
طلب موعد

المنشورات

  1. Joyner MJ, Carter RE, Wright RS, Senefeld JW. The Safety Profile of COVID-19 Convalescent Plasma. Curr Top Microbiol Immunol. 2024 Dec 19 [Epub ahead of print]
    View PubMed
  2. Manzato M, Wright RS, Jaffe AS, Vasile VC. Lipoprotein (a): Underrecognized Risk with a Promising Future. Rev Cardiovasc Med. 2024 Nov; 25 (11):393 Epub 2024 Nov 06
    View PubMed
  3. Wright RS, Raal FJ, Koenig W, Landmesser U, Leiter LA, Vikarunnessa S, Lesogor A, Maheux P, Talloczy Z, Zang X, Schwartz GG, Ray KK. Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial. Cardiovasc Res. 2024 Oct 14; 120 (12):1400-1410
    View PubMed
  4. Dragotakes Q, Johnson PW, Buras MR, Carter RE, Joyner MJ, Bloch E, Gebo KA, Hanley DF, Henderson JP, Pirofski LA, Shoham S, Senefeld JW, Tobian AAR, Wiggins CC, Wright RS, Paneth NS, Sullivan DJ, Casadevall A. Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2024 Oct 8; 121 (41):e2414957121 Epub 2024 Oct 01
    View PubMed
  5. Vaszar LT, Sharp RR, Carter RE, Wright RS. Pragmatic Clinical Trials: The Ethics of Conducting Research in the Real World. Mayo Clin Proc. 2024 Sep; 99 (9):1369-1373 Epub 2024 Aug 05
    View PubMed
  6. Leiter LA, Raal FJ, Schwartz GG, Koenig W, Ray KK, Landmesser U, Han J, Conde LG, Wright RS. Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials. Diabetes Obes Metab. 2024 Aug; 26 (8):3223-3237 Epub 2024 May 17
    View PubMed
  7. Wright RS, Ray KK, Landmesser U, Koenig W, Raal FJ, Leiter LA, Conde LG, Han J, Schwartz GG. Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials. Mayo Clin Proc. 2024 Jul 5 Epub 2024 July 05
    View PubMed
  8. Koenig W, Conde LG, Landmesser U, Leiter LA, Ray KK, Schwartz GG, Wright RS, Han J, Raal FJ. Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials. Cardiovasc Drugs Ther. 2024 Jun; 38 (3):493-503 Epub 2022 Dec 23
    View PubMed
  9. Ray KK, Gunn LH, Conde LG, Raal FJ, Wright RS, Gosselin NH, Leiter LA, Koenig W, Schwartz GG, Landmesser U, ORION investigators. Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention. Atherosclerosis. 2024 Apr; 391:117472 Epub 2024 Feb 15
    View PubMed
  10. Wright RS, Koenig W, Landmesser U, Leiter LA, Raal FJ, Schwartz GG, Lesogor A, Maheux P, Stratz C, Zang X, Ray KK. Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials. J Am Coll Cardiol. 2023 Dec 12; 82 (24):2251-2261
    View PubMed
  11. Landmesser U, Koenig W, Leiter LA, Raal FJ, Ray KK, Wright RS, Han J, Conde LG, Schwartz GG. Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials. Atherosclerosis. 2023 Dec; 386:117354 Epub 2023 Oct 18
    View PubMed
  12. Senefeld JW, Gorman EK, Johnson PW, Moir ME, Klassen SA, Carter RE, Paneth NS, Sullivan DJ, Morkeberg OH, Wright RS, Fairweather D, Bruno KA, Shoham S, Bloch EM, Focosi D, Henderson JP, Juskewitch JE, Pirofski LA, Grossman BJ, Tobian AAR, Franchini M, Ganesh R, Hurt RT, Kay NE, Parikh SA, Baker SE, Buchholtz ZA, Buras MR, Clayburn AJ, Dennis JJ, Diaz Soto JC, Herasevich V, Klompas AM, Kunze KL, Larson KF, Mills JR, Regimbal RJ, Ripoll JG, Sexton MA, Shepherd JRA, Stubbs JR, Theel ES, van Buskirk CM, van Helmond N, Vogt MNP, Whelan ER, Wiggins CC, Winters JL, Casadevall A, Joyner MJ. Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis. Mayo Clin Proc Innov Qual Outcomes. 2023 Oct; 7 (5):499-513 Epub 2023 Oct 10
    View PubMed
  13. Koenig W, Ray KK, Landmesser U, Leiter LA, Schwartz GG, Wright RS, Conde LG, Han J, Raal FJ. Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11. Am J Prev Cardiol. 2023 Jun; 14:100503 Epub 2023 May 14
    View PubMed
  14. Ray KK, Wright RS. Plain language summary of results from ORION-10 and ORION-11: two studies to learn how well inclisiran works in people with high cholesterol. Future Cardiol. 2023 Mar; 19 (4):175-184 Epub 2023 June 06
    View PubMed
  15. Ray KK, Raal FJ, Kallend DG, Jaros MJ, Koenig W, Leiter LA, Landmesser U, Schwartz GG, Lawrence D, Friedman A, Garcia Conde L, Wright RS, ORION Phase III investigators. Inclisiran and cardiovascular events: a patient-level analysis of phase III trials. Eur Heart J. 2023 Jan 7; 44 (2):129-138
    View PubMed
  16. Ray KK, Troquay RPT, Visseren FLJ, Leiter LA, Wright RS, Vikarunnessa S, Talloczy Z, Zang X, Maheux P, Lesogor A, Landmesser U. Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial. The Lancet Diabetes and Endocrinology. 2023; 11 (2):109-19
  17. Ray KK, Kallend D, Leiter LA, Raal FJ, Koenig W, Jaros MJ, Schwartz GG, Landmesser U, Garcia Conde L, Wright RS, ORION-11 Investigators. Effect of inclisiran on lipids in primary prevention: the ORION-11 trial. Eur Heart J. 2022 Dec 21; 43 (48):5047-5057
    View PubMed
  18. Greason KL, Spittell PC, Wright RS. Chordal Preservation Mitral Valve Replacement for Delayed MitraClip Failure. Tex Heart Inst J. 2022 Nov 1; 49 (6)
    View PubMed
  19. Ray KK, Wright RS. Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk. JAMA 2021 Dec 7; 326 (21):2205
    View PubMed
  20. Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van Helmond N, Golafshar MA, Klassen SA, Klompas AM, Sexton MA, Diaz Soto JC, Grossman BJ, Tobian AAR, Goel R, Wiggins CC, Bruno KA, van Buskirk CM, Stubbs JR, Winters JL, Casadevall A, Paneth NS, Shaz BH, Petersen MM, Sachais BS, Buras MR, Wieczorek MA, Russoniello B, Dumont LJ, Baker SE, Vassallo RR, Shepherd JRA, Young PP, Verdun NC, Marks P, Haley NR, Rea RF, Katz L, Herasevich V, Waxman DA, Whelan ER, Bergman A, Clayburn AJ, Grabowski MK, Larson KF, Ripoll JG, Andersen KJ, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Buchholtz ZA, Pletsch MC, Wright K, Greenshields JT, Joyner MJ, Wright RS, Carter RE, Fairweather D. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. PLoS Med. 2021 Dec; 18 (12):e1003872 Epub 2021 Dec 20
    View PubMed
  21. Lapid MI, Clarke BL, Ho JB, Ouellette Y, Armbrust TL, Wright RS. Research Involving Participants With Impaired Consent Capacity: An Examination of Methods to Determine Capacity to Consent. Mayo Clin Proc. 2021 Nov; 96 (11):2806-2822
    View PubMed
  22. Kunze KL, Johnson PW, van Helmond N, Senefeld JW, Petersen MM, Klassen SA, Wiggins CC, Klompas AM, Bruno KA, Mills JR, Theel ES, Buras MR, Golafshar MA, Sexton MA, Diaz Soto JC, Baker SE, Shepherd JRA, Verdun NC, Marks P, Paneth NS, Fairweather D, Wright RS, van Buskirk CM, Winters JL, Stubbs JR, Senese KA, Pletsch MC, Buchholtz ZA, Rea RF, Herasevich V, Whelan ER, Clayburn AJ, Larson KF, Ripoll JG, Andersen KJ, Lesser ER, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Casadevall A, Carter RE, Joyner MJ. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 Aug 11; 12 (1):4864
    View PubMed
  23. Senefeld JW, Klassen SA, Ford SK, Senese KA, Wiggins CC, Bostrom BC, Thompson MA, Baker SE, Nicholson WT, Johnson PW, Carter RE, Henderson JP, Hartman WR, Pirofski LA, Wright RS, Fairweather L, Bruno KA, Paneth NS, Casadevall A, Joyner MJ. Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion. 2021 Aug; 61 (8):2503-2511 Epub 2021 June 01
    View PubMed
  24. Casadevall A, Dragotakes Q, Johnson PW, Senefeld JW, Klassen SA, Wright RS, Joyner MJ, Paneth N, Carter RE. Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality. Elife. 2021 Jun 4; 10 Epub 2021 June 04
    View PubMed
  25. Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser J, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski LA, Baker SE, van Helmond N, Wright RS, Fairweather D, Bruno KA, Wang Z, Paneth NS, Casadevall A, Joyner MJ. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 May; 96 (5):1262-1275 Epub 2021 Feb 17
    View PubMed
  26. Rhainds D, Packard CJ, Brodeur MR, Niesor EJ, Sacks FM, Jukema JW, Wright RS, Waters DD, Heinonen T, Black DM, Laghrissi-Thode F, Dube MP, Pfeffer MA, Tardif JC. Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine. Circ Genom Precis Med. 2021 Apr; 14 (2):e003219 Epub 2021 Apr 02
    View PubMed
  27. Joyner MJ, Carter RE, Senefeld JW, Klassen SA, Mills JR, Johnson PW, Theel ES, Wiggins CC, Bruno KA, Klompas AM, Lesser ER, Kunze KL, Sexton MA, Diaz Soto JC, Baker SE, Shepherd JRA, van Helmond N, Verdun NC, Marks P, van Buskirk CM, Winters JL, Stubbs JR, Rea RF, Hodge DO, Herasevich V, Whelan ER, Clayburn AJ, Larson KF, Ripoll JG, Andersen KJ, Buras MR, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Paneth NS, Fairweather D, Wright RS, Casadevall A. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 Mar 18; 384 (11):1015-1027 Epub 2021 Jan 13
    View PubMed
  28. Wright RS, Ray KK, Raal FJ, Kallend DG, Jaros M, Koenig W, Leiter LA, Landmesser U, Schwartz GG, Friedman A, Wijngaard PLJ, Garcia Conde L, Kastelein JJP, ORION Phase III Investigators. Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis. J Am Coll Cardiol. 2021 Mar 9; 77 (9):1182-1193
    View PubMed
  29. Landmesser U, Haghikia A, Leiter LA, Wright RS, Kallend D, Wijngaard P, Stoekenbroek R, Kastelein JJ, Ray KK. Effect of inclisiran, the small-interfering RNA against proprotein convertase subtilisin/kexin type 9, on platelets, immune cells, and immunological biomarkers: a pre-specified analysis from ORION-1. Cardiovasc Res. 2021 Jan 1; 117 (1):284-291
    View PubMed
  30. Ma T, Wiggins CC, Kornatowski BM, Hailat RS, Clayburn AJ, Guo WL, Johnson PW, Senefeld JW, Klassen SA, Baker SE, Bruno KA, Fairweather D, Wright RS, Carter RE, Li C, Joyner MJ, Paneth NS. The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma. Front Med (Lausanne). 2021; 8:707895 Epub 2022 Jan 26
    View PubMed
  31. Klassen SA, Senefeld JW, Senese KA, Johnson PW, Wiggins CC, Baker SE, van Helmond N, Bruno KA, Pirofski LA, Shoham S, Grossman BJ, Henderson JP, Wright RS, Fairweather D, Paneth NS, Carter RE, Casadevall A, Joyner MJ. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151 Epub 2021 June 07
    View PubMed
  32. Lapid MI, Meagher KM, Giunta HC, Clarke BL, Ouellette Y, Armbrust TL, Sharp RR, Wright RS. Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists. Mayo Clin Proc. 2021 Jan; 96 (1):165-173 Epub 2020 Oct 23
    View PubMed
  33. Gharacholou SM, Del-Carpio Munoz F, Motiei A, Sandhu GS, Barsness GW, Gulati R, Wright RS, Pellikka PA, Lewis B, Johnson MP, Lane GE, Pollak PM, Pillai DP, Sabbagh AE, Paul TK, Pham SM, Singh M. Characteristics and Long-Term Outcomes of Patients With Prior Coronary Artery Bypass Grafting Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2020 Nov 15; 135:1-8. Epub 2020 Aug 28.
    View PubMed
  34. Andersen KJ, Klassen SA, Larson KF, Ripoll JG, Senefeld JW, Clayburn AJ, Shepherd JRA, Tseng AS, Wiggins CC, Murphy BM, Ford SK, Johnson CP, Miller AD, Baker SE, Wright RS, Winters JL, Stubbs JR, Joyner MJ, van Buskirk CM. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors. Mayo Clin Proc. 2020 Nov; 95 (11):2343-2349 Epub 2020 Sept 21
    View PubMed
  35. Joyner MJ, Wright RS, Fairweather D, Senefeld JW, Bruno KA, Klassen SA, Carter RE, Klompas AM, Wiggins CC, Shepherd JR, Rea RF, Whelan ER, Clayburn AJ, Spiegel MR, Johnson PW, Lesser ER, Baker SE, Larson KF, Ripoll JG, Andersen KJ, Hodge DO, Kunze KL, Buras MR, Vogt MN, Herasevich V, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Van Buskirk CM, Winters JL, Stubbs JR, Paneth NS, Verdun NC, Marks P, Casadevall A. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 Sep 1; 130 (9):4791-4797
    View PubMed
  36. Joyner MJ, Bruno KA, Klassen SA, Kunze KL, Johnson PW, Lesser ER, Wiggins CC, Senefeld JW, Klompas AM, Hodge DO, Shepherd JRA, Rea RF, Whelan ER, Clayburn AJ, Spiegel MR, Baker SE, Larson KF, Ripoll JG, Andersen KJ, Buras MR, Vogt MNP, Herasevich V, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, van Buskirk CM, Winters JL, Stubbs JR, van Helmond N, Butterfield BP, Sexton MA, Diaz Soto JC, Paneth NS, Verdun NC, Marks P, Casadevall A, Fairweather D, Carter RE, Wright RS. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020 Sep; 95 (9):1888-1897 Epub 2020 July 19
    View PubMed
  37. Sher T, Wright RS. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19. Mayo Clin Proc. 2020 Jun; 95 (6):1130-1131 Epub 2020 Apr 20
    View PubMed
  38. Meagher KM, Cummins NW, Bharucha AE, Badley AD, Chlan LL, Wright RS. COVID-19 Ethics and Research. Mayo Clin Proc. 2020 Jun; 95 (6):1119-1123 Epub 2020 Apr 24
    View PubMed
  39. Joyner M, Wright RS, Fairweather D, Senefeld J, Bruno K, Klassen S, Carter R, Klompas A, Wiggins C, Shepherd JR, Rea R, Whelan E, Clayburn A, Spiegel M, Johnson P, Lesser E, Baker S, Larson K, Ripoll Sanz J, Andersen K, Hodge D, Kunze K, Buras M, Vogt M, Herasevich V, Dennis J, Regimbal R, Bauer P, Blair J, van Buskirk C, Winters J, Stubbs J, Paneth N, Casadevall A. Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients. medRxiv 2020 May 14
    View PubMed
  40. Ray KK, Wright RS, Kallend D, Koenig W, Leiter LA, Raal FJ, Bisch JA, Richardson T, Jaros M, Wijngaard PLJ, Kastelein JJP, ORION-10 and ORION-11 Investigators. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. N Engl J Med. 2020 Apr 16; 382 (16):1507-1519 Epub 2020 Mar 18
    View PubMed
  41. Raal FJ, Kallend D, Ray KK, Turner T, Koenig W, Wright RS, Wijngaard PLJ, Curcio D, Jaros MJ, Leiter LA, Kastelein JJP, ORION-9 Investigators. Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia. N Engl J Med. 2020 Apr 16; 382 (16):1520-1530 Epub 2020 Mar 18
    View PubMed
  42. Wright RS, Collins MG, Stoekenbroek RM, Robson R, Wijngaard PLJ, Landmesser U, Leiter LA, Kastelein JJP, Ray KK, Kallend D. Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies. Mayo Clin Proc. 2020 Jan; 95 (1):77-89 Epub 2019 Oct 17
    View PubMed
  43. Ray KK, Stoekenbroek RM, Kallend D, Nishikido T, Leiter LA, Landmesser U, Wright RS, Wijngaard PLJ, Kastelein JJP. Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial. JAMA Cardiol. 2019 Nov 1; 4 (11):1067-1075
    View PubMed
  44. Raal FJ, Tuomilehto J, Sposito AC, Fonseca FA, Averna M, Farnier M, Santos RD, Ferdinand KC, Wright RS, Navarese EP, Lerch DM, Louie MJ, Lee LV, Letierce A, Robinson JG. Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies. J Clin Lipidol. 2019 Sep - Oct; 13 (5):735-743 Epub 2019 June 29
    View PubMed
  45. Jentzer JC, van Diepen S, Barsness GW, Katz JN, Wiley BM, Bennett CE, Mankad SV, Sinak LJ, Best PJ, Herrmann J, Jaffe AS, Murphy JG, Morrow DA, Wright RS, Bell MR, Anavekar NS. Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population. Am Heart J. 2019 Sep; 215:12-19 Epub 2019 June 04
    View PubMed
  46. Bennett CE, Wright RS, Jentzer J, Gajic O, Murphree DH, Murphy JG, Mankad SV, Wiley BM, Bell MR, Barsness GW. Severity of illness assessment with application of the APACHE IV predicted mortality and outcome trends analysis in an academic cardiac intensive care unit. J Crit Care. 2019 Apr; 50:242-246 Epub 2018 Dec 24
    View PubMed
  47. Lapid MI, Clarke BL, Wright RS. Institutional Review Boards: What Clinician Researchers Need to Know. Mayo Clin Proc. 2019 Mar; 94 (3):515-525
    View PubMed
  48. Leiter LA, Teoh H, Kallend D, Wright RS, Landmesser U, Wijngaard PLJ, Kastelein JJP, Ray KK. Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial. Diabetes Care. 2019 Jan; 42 (1):173-176 Epub 2018 Nov 28
    View PubMed
  49. Jentzer JC, Murphree DH, Wiley B, Bennett C, Goldfarb M, Keegan MT, Murphy JG, Wright RS, Barsness GW. Comparison of Mortality Risk Prediction Among Patients >/=70 Versus <70 Years of Age in a Cardiac Intensive Care Unit. Am J Cardiol. 2018 Nov 15; 122 (10):1773-1778 Epub 2018 Aug 22
    View PubMed
  50. Ray KK, Stoekenbroek RM, Kallend D, Leiter LA, Landmesser U, Wright RS, Wijngaard P, Kastelein JJP. Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Prespecified Secondary End Points in ORION 1. Circulation. 2018 Sep 25; 138 (13):1304-1316
    View PubMed
  51. Nicholls SJ, Puri R, Ballantyne CM, Jukema JW, Kastelein JJP, Koenig W, Wright RS, Kallend D, Wijngaard P, Borgman M, Wolski K, Nissen SE. Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018 Sep 1; 3 (9):806-814
    View PubMed
  52. Jentzer JC, Bennett C, Wiley BM, Murphree DH, Keegan MT, Gajic O, Wright RS, Barsness GW. Predictive Value of the Sequential Organ Failure Assessment Score for Mortality in a Contemporary Cardiac Intensive Care Unit Population. J Am Heart Assoc. 2018 Mar 10; 7 (6)
    View PubMed
  53. Jentzer JC, Clements CM, Murphy JG, Wright RS, Scott Wright R. Recent developments in the management of patients resuscitated from cardiac arrest. J Crit Care. 2017 Jun; 39:97-107 Epub 2017 Feb 16
    View PubMed
  54. Le RJ, Cullen MW, Lahr BD, Wright RS, Kopecky SL. Side Effects of CV Medications Following Hospitalization for ACS Are Associated With More Frequent Health-Care Contacts. J Cardiovasc Pharmacol Ther. 2017 May; 22 (3):250-255 Epub 2016 Oct 02
    View PubMed
  55. Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC, SPIRE Cardiovascular Outcome Investigators. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. N Engl J Med. 2017 Apr 20; 376 (16):1527-1539 Epub 2017 Mar 17
    View PubMed
  56. Ray KK, Landmesser U, Leiter LA, Kallend D, Dufour R, Karakas M, Hall T, Troquay RP, Turner T, Visseren FL, Wijngaard P, Wright RS, Kastelein JJ. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol. N Engl J Med. 2017 Apr 13; 376 (15):1430-1440 Epub 2017 Mar 17
    View PubMed
  57. Jentzer JC, Clements CM, Wright RS, White RD, Jaffe AS. Improving Survival From Cardiac Arrest: A Review of Contemporary Practice and Challenges. Ann Emerg Med. 2016 Dec; 68 (6):678-689 Epub 2016 June 16
    View PubMed
  58. Wang F, Gulati R, Lennon RJ, Lewis BR, Park J, Sandhu GS, Wright RS, Lerman A, Herrmann J. Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Mayo Clin Proc. 2016 Dec; 91 (12):1680-1692
    View PubMed
  59. Stahli BE, Gebhard C, Duchatelle V, Cournoyer D, Petroni T, Tanguay JF, Robb S, Mann J, Guertin MC, Wright RS, L L'Allier P, Tardif JC. Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial. J Am Heart Assoc. 2016 Nov 16; 5 (11)
    View PubMed
  60. Siontis KC, Barsness GW, Lennon RJ, Holmen JL, Wright RS, Bell MR, Gersh BJ. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network). Am J Cardiol. 2016 Jun 15; 117: (12)1904-10.
    View PubMed
  61. Sakhuja A, Wright RS, Schold JD, McCarthy JT, Williams AW, Amer H, Albright RC. National Impact of Maintenance Dialysis or Renal Transplantation on Outcomes Following ST Elevation Myocardial Infarction. Am J Nephrol. 2016; 44: (5)329-338.
    View PubMed
  62. Gupta BP, Steckelberg RC, Gullerud RE, Huddleston PM, Kirkland LL, Wright RS, Huddleston JM. Incidence and 1-Year Outcomes of Perioperative Atrial Arrhythmia in Elderly Adults After Hip Fracture Surgery. J Am Geriatr Soc. 2015 Nov; 63 (11):2269-74 Epub 2015 Oct 27
    View PubMed
  63. Henkin S, Negrotto S, Pollak PM, Cullen MW, O'Cochlain DF, Wright RS. Platypnea-Orthodeoxia Syndrome: Diagnostic Challenge and the Importance of Heightened Clinical Suspicion. Tex Heart Inst J. 2015 Oct; 42(5):498-501.
    View PubMed
  64. Villablanca PA, Alegria JR, Mookadam F, Holmes DR Jr, Wright RS, Levine JA. Nonexercise activity thermogenesis in obesity management. Mayo Clin Proc. 2015 Apr; 90(4):509-19.
    View PubMed
  65. Lopez-Jimenez F, Simha V, Thomas RJ, Allison TG, Basu A, Fernandes R, Hurst RT, Kopecky SL, Kullo IJ, Mulvagh SL, Thompson WG, Trejo-Gutierrez JF, Wright RS. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps. Mayo Clin Proc. 2014 Sep; 89 (9):1257-78 Epub 2014 Aug 12
    View PubMed
  66. Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE, VISTA-16 Investigators. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA. 2014 Jan 15; 311(3):252-62.
    View PubMed
  67. Killu AM, Wright RS, Kopecky SL. Questions and answers on proper peri-operative management of antiplatelet therapy after coronary stent implantation to prevent stent thrombosis. Am J Cardiol. 2013 Oct 1; 112(7):1046-50. Epub 2013 Jul 25.
    View PubMed
  68. Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, Herges RM, Howard DE, Somers VK. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013 Aug 13; 62(7):610-6. Epub 2013 Jun 13.
    View PubMed
  69. Wright RS. Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol. Curr Opin Cardiol. 2013 Jul; 28(4):389-98.
    View PubMed
  70. Tardif JC, Tanguay JF, Wright SS, Duchatelle V, Petroni T, Gregoire JC, Ibrahim R, Heinonen TM, Robb S, Bertrand OF, Cournoyer D, Johnson D, Mann J, Guertin MC, L'Allier PL. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J Am Coll Cardiol. 2013 May 21; 61(20):2048-55. Epub 2013 Mar 10.
    View PubMed
  71. Nicholls SJ, Kastelein JP, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE, VISTA-16 Investigators. Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome The VISTA-16 Randomized Clinical Trial. JAMA 1001/jama282836. 2013.
  72. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS, dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Nov 29; 367 (22):2089-99 Epub 2012 Nov 05
    View PubMed
  73. Jouni H, Driver SL, Wright RS, Timimi F. Danger above: a classic case of an unruptured right sinus of Valsalva aneurysm. BMJ Case Rep. 2012 Nov 27; 2012
    View PubMed
  74. Rosenson RS, Wright RS, Farkouh M, Plutzky J. Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects. Am Heart J. 2012 Nov; 164(5):672-80. Epub 2012 Oct 16.
    View PubMed
  75. Gupta BP, Huddleston JM, Kirkland LL, Huddleston PM, Larson DR, Gullerud RE, Burton MC, Rihal CS, Wright RS. Clinical presentation and outcome of perioperative myocardial infarction in the very elderly following hip fracture surgery. J Hosp Med. 2012 Nov-Dec; 7 (9):713-6 Epub 2012 Sept 06
    View PubMed
  76. Khambatta S, Farkouh ME, Wright RS, Reeder GS, McCullough PA, Smars PA, Hickson LJ, Best PJ. Chronic kidney disease as a risk factor for acute coronary syndromes in patients presenting to the emergency room with chest pain. Transl Res. 2012 May; 159(5):391-6. Epub 2012 Jan 09.
    View PubMed
  77. Meyer SR, Suri RM, Wright RS, Dearani JA, Orszulak TA, Daly RC, Burkhart HM, Park SJ, Schaff HV. Does metabolic syndrome influence bioprosthetic mitral valve degeneration and reoperation rate? J Card Surg. 2012 Mar; 27(2):146-51.
    View PubMed
  78. Sert Kuniyoshi FH, Singh P, Gami AS, Garcia-Touchard A, van der Walt C, Pusalavidyasagar S, Wright RS, Vasquez EC, Lopez-Jimenez F, Somers VK. Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction. Chest. 2011 Jul; 140 (1):62-67 Epub 2011 Feb 24
    View PubMed
  79. Wright RS, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 May 10; 57 (19):1920-59 Epub 2011 Mar 28
    View PubMed
  80. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Zidar JP, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 May 10; 57 (19):e215-367
    View PubMed
  81. Record J, Beasley B, McDonald FS, Wright S. Major concerns about internal medicine: insights from program directors. South Med J. 2011 Feb; 104(2):89-94.
    View PubMed
  82. Chen HH, Martin FL, Gibbons RJ, Schirger JA, Wright RS, Schears RM, Redfield MM, Simari RD, Lerman A, Cataliotti A, Burnett JC Jr. Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart. 2009 Aug; 95 (16):1315-9 Epub 2009 May 15
    View PubMed
  83. Hoelzer BC, Weingarten TN, Hooten WM, Wright RS, Wilson WR, Wilson PR. Paraspinal abscess complicated by endocarditis following a facet joint injection. Eur J Pain. 2008 Apr; 12 (3):261-5 Epub 2007 July 02
    View PubMed
  84. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr., Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Kass Wenger N, Wright R, Smith SC Jr., Jacobs AK. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Journal of the American College of Cardiology.2007 Aug 14;50:(7):e1-e157.
  85. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007 Jul 31; 50 (5):448-52 Epub 2007 July 16
    View PubMed
  86. Powell BD, Bybee KA, Valeti U, Thomas RJ, Kopecky SL, Mullany CJ, Wright RS. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2007 Mar 15; 99(6):785-9. Epub 2007 Jan 18.
    View PubMed
  87. Holtan SG, Allen RD, Henkel DM, Kamal AH, Novak GD, O'Cochlain F, Chandrasekaran K, Mullany CJ, Wright RS. Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena. Int J Cardiol. 2007; 115(1):E8-9.
  88. Bybee KA, Motiei A, Syed IS, Kara T, Prasad A, Lennon RJ, Murphy JG, Hammill SC, Rihal CS, Wright RS. Electrocardiography cannot reliably differentiate transient left ventricular apical ballooning syndrome from anterior ST-segment elevation myocardial infarction. J Electrocardiol. 2007 Jan; 40(1):38.e1-6. Epub 2006 Oct 25.
    View PubMed
  89. Gumina RJ, Murphy JG, Rihal CS, Lennon RJ, Wright RS. Long-term survival after right ventricular infarction. Am J Cardiol. 2006 Dec 15; 98: (12)1571-3.
    View PubMed
  90. Gau GT, Wright RS. Pathophysiology, diagnosis, and management of dyslipidemia. Curr Probl Cardiol. 2006 Jul; 31(7):445-86.
    View PubMed
  91. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006 Jun 16; 110 (2):153-9 Epub 2005 July 25
    View PubMed
  92. Briel M, Schwartz GG, Thompson PL, de Lemos JA, Blazing MA, van Es GA, Kayikcioglu M, Arntz HR, den Hartog FR, Veeger NJ, Colivicchi F, Dupuis J, Okazaki S, Wright RS, Bucher HC, Nordmann AJ. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA. 2006 May 3; 295(17):2046-56.
    View PubMed
  93. Wright RS, Bybee K, Miller WL, Laudon DA, Murphy JG, Jaffe AS. Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI. Int J Cardiol. 2006 Apr 14; 108(3):314-9. Epub 2005 Jun 22.
    View PubMed
  94. Bybee KA, Murphy J, Prasad A, Wright RS, Lerman A, Rihal CS, Chareonthaitawee P. Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome. J Nucl Cardiol. 2006 Mar-Apr; 13 (2):244-50
    View PubMed
  95. Williams BA, Wright RS, Murphy JG, Brilakis ES, Reeder GS, Jaffe AS. A new simplified immediate prognostic risk score for patients with acute myocardial infarction. Emerg Med J. 2006 Mar; 23 (3):186-92
    View PubMed
  96. Haro LH, Decker WW, Boie ET, Wright RS. Initial approach to the patient who has chest pain. Cardiol Clin. 2006 Feb; 24(1):1-17, v.
    View PubMed
  97. Ensminger SA, Wright RS, Baddour LM, Afessa B. Suspected ventilator-associated pneumonia in cardiac patients admitted to the coronary care unit. Mayo Clin Proc. 2006 Jan; 81(1):32-5.
    View PubMed
  98. Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005 Sep 1; 96: (5)611-6.
    View PubMed
  99. Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C, Wright RS. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation. 2005 Aug 30; 112 (9 Suppl):I286-92
    View PubMed
  100. Sierra-Johnson J, Wright RS, Lopez-Jimenez F, Allison TG. Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation. Am J Cardiol. 2005 Jul 15; 96: (2)211-4.
    View PubMed
  101. Cabalka AK, Hagler DJ, Mookadam F, Chandrasekaran K, Wright RS. Percutaneous closure of left ventricular-to-right atrial fistula after prosthetic mitral valve rereplacement using the Amplatzer duct occluder. Catheter Cardiovasc Interv. 2005 Apr; 64(4):522-7.
    View PubMed
  102. Gilman G, Wright RS, Glockner JF, Starrett RS, Hansen WH, Sinak LJ, Tazelaar HD, Tajik AJ, Dearani JA. Ventricular septal hamartoma mimicking hypertrophic cardiomyopathy in a 41-year-old woman presenting with paroxysmal supraventricular tachycardia. J Am Soc Echocardiogr. 2005 Mar; 18 (3):272-4
    View PubMed
  103. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004 Dec 7; 141 (11):858-65
    View PubMed
  104. Spencer FA, Fonarow GC, Frederick PD, Wright RS, Every N, Goldberg RJ, Gore JM, Dong W, Becker RC, French W. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction - National Registry of Myocardial Infarction. Arch Intern Med. 2004 Oct 25; 164(19):2162-8.
    View PubMed
  105. Bybee KA, Kopecky SL, Williams BA, Murphy JG, Wright RS. Reduced creatine kinase release with statin use at the time of myocardial infarction. Int J Cardiol. 2004 Sep; 96(3):461-6.
    View PubMed
  106. Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, Wright RS, Rihal CS. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004 Aug 1; 94 (3):343-6
    View PubMed
  107. Bybee KA, Powell BD, Williams BA, Murphy JG, Kopecky SL, Wright RS. Superior short-term cholesterol control and achievement of the adult treatment panel III low-density lipoprotein goals with initiation of statin therapy by the time of hospital discharge following acute myocardial infarction. Am J Cardiol. 2004 Mar 15; 93(6):776-9.
    View PubMed
  108. Hillis GS, Moller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, Reeder GS, Oh JK. Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol. 2004 Feb 4; 43 (3):360-7
    View PubMed
  109. Xue J, Aufderheide T, Wright RS, Klein J, Farrell R, Rowlandson I, Young B. Added value of new acute coronary syndrome computer algorithm for interpretation of prehospital electrocardiograms. J Electrocardiol. 2004; 37(Suppl S):233-9.
    View PubMed
  110. Brilakis ES, Wright RS, Kopecky SL, Mavrogiorgos NC, Reeder GS, Rihal CS, Gersh BJ, Williams BA, Clements IP. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J. 2003 Nov; 146 (5):811-8
    View PubMed
  111. Murphy JG, Wright RS, Bruce GK, Baddour LM, Farrell MA, Edwards WD, Kita H, Cooper LT. Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet. 2003 Oct 25; 362(9393):1378-80.
    View PubMed
  112. Hillis GS, Mulvagh SL, Pellikka PA, Hagen ME, Gunda M, Wright RS, Oh JK. Comparison of intravenous myocardial contrast echocardiography and low-dose dobutamine echocardiography for predicting left ventricular functional recovery following acute myocardial infarction. Am J Cardiol. 2003 Sep 1; 92 (5):504-8
    View PubMed
  113. Tedesco JV, Williams BA, Wright RS, Reeder GS, Dvorak D, Kopecky SL, Miller WL, Coronary Care Unit Group. Baseline comorbidities and treatment strategy in elderly patients are associated with outcome of cardiogenic shock in a community-based population. Am Heart J. 2003 Sep; 146(3):472-8.
    View PubMed
  114. Gami AS, Wright RS, Ballman KV, Kopecky SL, Hayes SN. Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus. Am J Cardiol. 2003 May 15; 91(10):1275-7.
    View PubMed
  115. Moller JE, Hillis GS, Oh JK, Seward JB, Reeder GS, Wright RS, Park SW, Bailey KR, Pellikka PA. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation. 2003 May 6; 107 (17):2207-12 Epub 2003 Apr 14
    View PubMed
  116. Tedesco JV, Wright RS, Williams BA, Kopecky SL, Dvorak DL, Reeder GS, Miller WL, Mayo Coronary Care Unit Group. Effect of diabetes on the mortality risk of cardiogenic shock in a community-based population. Mayo Clin Proc. 2003 May; 78 (5):561-6
    View PubMed
  117. Murphy J, Wright RS, Gussak I, Williams B, Daly RN, Cain VA, Pieniaszek HJ, Sy SK, Ebling W, Simonson K, Wilcox RA, Kopecky SL. The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease. Am J Cardiovasc Drugs. 2003; 3 (2):101-12
    View PubMed
  118. Grines C, Nair R, Wright RS. Contemporary management of acute MI. Patient Care. 2003; 37(8):14-28.
  119. Gumina RJ, Wright RS, Kopecky SL, Miller WL, Williams BA, Reeder GS, Murphy JG. Strong predictive value of TIMI risk score analysis for in-hospital and long-term survival of patients with right ventricular infarction. Eur Heart J. 2002 Nov; 23 (21):1678-83
    View PubMed
  120. Aviles RJ, Wright RS, Aviles JM, McDonald F, Ballman K, Harker-Murray A, Scott C, Lauer MS, Kopecky SL, Jaffe AS. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin i levels. Am J Cardiol. 2002 Oct 15; 90 (8):875-8
    View PubMed
  121. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002 Oct 1; 137 (7):563-70
    View PubMed
  122. Wright RS, Murphy JG, Bybee KA, Kopecky SL, LaBlanche JM. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit. Mayo Clin Proc. 2002 Oct; 77(10):1085-92.
    View PubMed
  123. Wright RS, Williams BA, Cramner H, Gallahue F, Willmore T, Lewis L, Ladenson JH, Jaffe AS. Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am J Cardiol. 2002 Sep 15; 90 (6):634-6
    View PubMed
  124. Bybee KA, Wright RS, Kopecky SL. Effect of early statin therapy after acute coronary syndromes: a concise review of the recent data. Cardiol Rev. 2002 Sep-Oct; 10 (5):301-5
    View PubMed
  125. Cantwell RV, Aviles RJ, Bjornsson J, Wright RS, Freeman WK, Oh JK, Hoyer JD, Markovic S, Jaffe AS. Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris. Clin Cardiol. 2002 Jan; 25 (1):33-7
    View PubMed
  126. Holland AE, Wright RS, Kopecky SL. Educating Investigative Sites: Bridging the Knowledge Gap in Clinical Trials. Clinical Researcher. 2002; 2(6):14-8.
  127. Wright RS, Barsness GW. Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy. Curr Interv Cardiol Rep. 2001 Nov; 3 (4):330-335
    View PubMed
  128. Miller WL, Wright RS, McGregor CG, Dispenzieri A, McConnell JP, Burritt MF, Jaffe AS. Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation. Am J Cardiol. 2001 Oct 1; 88 (7):813-5
    View PubMed
  129. Wright RS, Kopecky SL, Timm M, Pflaum DD, Carr C, Evers K, Bell J, Wabasha Heart Attack Team. Impact of community-based education on health care evaluation in patients with acute chest pain syndromes: the Wabasha Heart Attack Team (WHAT) project. Fam Pract. 2001 Oct; 18 (5):537-9
    View PubMed
  130. Brilakis ES, Wright RS, Kopecky SL, Reeder GS, Williams BA, Miller WL. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol. 2001 Aug 1; 88 (3):205-9
    View PubMed
  131. Suwaidi JA, Wright RS, Grill JP, Hensrud DD, Murphy JG, Squires RW, Kopecky SL. Obesity is associated with premature occurrence of acute myocardial infarction. Clin Cardiol. 2001 Aug; 24 (8):542-7
    View PubMed
  132. Sgura FA, Wright RS, Kopecky SL, Grill JP, Reeder GS. Length of stay in myocardial infarction. Cost Qual. 2001 Jun; 12-20, 25
    View PubMed
  133. Miller WL, Sgura FA, Kopecky SL, Asirvatham SJ, Williams BA, Wright RS, Reeder GS. Characteristics of presenting electrocardiograms of acute myocardial infarction from a community-based population predict short- and long-term mortality. Am J Cardiol. 2001 May 1; 87 (9):1045-50
    View PubMed
  134. Bybee KA, Wright RS, Williams BA, Murphy JG, Holmes DR Jr, Holmes DR Jr, Kopecky SL. Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction. Am J Cardiol. 2001 Mar 15; 87 (6):771-4, A7
    View PubMed
  135. Xue J, Taha B, Reddy S, Wright RS, Aufderheide T. A new method to incorporate age and gender into the criteria for the detection of acute inferior myocardial infarction. J Electrocardiol. 2001; 34 Suppl:229-34.
    View PubMed
  136. Wright RS, Kopecky SL, Reeder GS. Update on intravenous fibrinolytic therapy for acute myocardial infarction. Mayo Clin Proc. 2000 Nov; 75 (11):1185-91; quiz 1192
    View PubMed
  137. Miller WL, Wright RS, Grill JP, Kopecky SL. Improved survival after acute myocardial infarction in patients with advanced Killip class. Clin Cardiol. 2000 Oct; 23 (10):751-8
    View PubMed
  138. Wright RS, Monnahan RL, Kopecky SL, Jones CT, Holmes DR Jr, Holmes DR Jr. Cardiac catheterization reduces resource utilization in patients with chronic chest pain. Catheter Cardiovasc Interv. 2000 Apr; 49 (4):363-6
    View PubMed
  139. Wright RS. Controversy: Inflammation and CAD. Minnesota Physician. 2000 Feb; XIII No. 11, 30.
  140. Gussak I, Wright RS, Kopecky SL, Hammill SC. Exercise-induced ST segment elevation in Q wave leads in postinfarction patients: defining its meaning and utility in today's practice. Cardiology. 2000; 93(4):205-9.
    View PubMed
  141. Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, Bjerregaard P. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000; 94 (2):99-102
    View PubMed
  142. Gussak I, Wright RS, Bjerregaard P, Chaitman BR, Zhou SH, Hammill SC, Kopecky SL. False-negative and false-positive ECG diagnoses of Q wave myocardial infarction in the presence of right bundle-branch block. Cardiology. 2000; 94 (3):165-72
    View PubMed
  143. Miller WL, Wright RS, Grill J, Kopecky S. Improved Short and Long-Term Survival of Acute Myocardial Infarction in Patients with Advanced Killip Class: Impact of Reperfusion Therapy and Adjunct Medical Therapy on Survival. Clin Card. 2000; 23:751-8.
  144. Verneuil A, Boeve BF, Fulgham JR, Johnson CM, Wright RS. Persistent cauda equina syndrome following bilateral aortoiliac dissection as a complication of cardiac angiography. Cathet Cardiovasc Diagn. 1997 Apr; 40(4):377-9.
    View PubMed
  145. Wright RS, Wei CM, Kim CH, Kinoshita M, Matsuda Y, Aarhus LL, Burnett JC Jr, Miller WL. C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems. J Am Coll Cardiol. 1996 Oct; 28 (4):1031-8
    View PubMed
  146. Clavell AL, Mattingly MT, Stevens TL, Nir A, Wright S, Aarhus LL, Heublein DM, Burnett JC Jr. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction. J Clin Invest. 1996 Mar 1; 97 (5):1286-92
    View PubMed
  147. Wright RS, Kopecky SL, Nishimura RA. Echocardiography in acute myocardial infarction. ACC Current Journal Review. 1996; 5(6):24-27.
  148. Wright RS, Kopecky SL. Streptokinase: a review. P T. 1995; 20(11 Suppl):4s-11s.
  149. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Wright S, Kao PC, Edwards WD, Burnett JC Jr. Endothelin in human congestive heart failure. Circulation. 1994 Apr; 89 (4):1580-6
    View PubMed
  150. Brandt RR, Wright RS, Redfield MM, Burnett JC Jr. Atrial natriuretic peptide in heart failure. J Am Coll Cardiol. 1993 Oct; 22 (4 Suppl A):86A-92A
    View PubMed
  151. Redfield MM, Aarhus LL, Wright RS, Burnett JC Jr. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation. 1993 Jun; 87 (6):2016-22
    View PubMed
  152. Wright RS, Simari RD, Orszulak TA, Edwards WD, Gleich GJ, Reeder GS. Eosinophilic endomyocardial disease presenting as cyanosis, platypnea, and orthodeoxia. Ann Intern Med. 1992 Sep 15; 117 (6):482-3
    View PubMed
  153. Wright RS, Anderson JW, Bridges SR. Propionate inhibits hepatocyte lipid synthesis. Experimental Biology & Medicine. 1990 Oct; 195(1):26-9.
    View PubMed